Lv2
120 积分 2023-04-18 加入
Antibody drug conjugates in metastatic brain tumors: current landscape, therapeutic potential and challenges
5天前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
19天前
已完结
Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study
20天前
已完结
Antibody-drug conjugates for non-small cell lung cancer: Advantages and challenges in clinical translation
1个月前
已完结
A comprehensive review of key factors affecting the efficacy of antibody drug conjugate
1个月前
已完结
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
1个月前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
1个月前
已完结
High levels of expression of Trop-2 in thymic epithelial tumors
1个月前
已完结
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
1个月前
已完结
Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients with Advanced Thymoma or Thymic Carcinoma
1个月前
已关闭
皖公网安备34019202002308
